Cleared Traditional

AMRESCO CREATININE REAGENTS PRODUCT #7790, 7791 (K900666) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K900666 · American Research Products Co. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
65d
Days
Class 2
Risk

K900666 is an FDA 510(k) clearance for the AMRESCO CREATININE REAGENTS PRODUCT #7790, 7791. Classified as Alkaline Picrate, Colorimetry, Creatinine (product code CGX), Class II - Special Controls.

Submitted by American Research Products Co. (Solon, US). The FDA issued a Cleared decision on April 19, 1990 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Research Products Co. devices

Submission Details

510(k) Number K900666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1990
Decision Date April 19, 1990
Days to Decision 65 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 88d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGX Alkaline Picrate, Colorimetry, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGX Alkaline Picrate, Colorimetry, Creatinine

All 39
Devices cleared under the same product code (CGX) and FDA review panel - the closest regulatory comparables to K900666.
ABBOTT QUICKSTART CREATININE TEST(CREA) ITEM# 5A28
K913707 · Em Diagnostic Systems, Inc. · Sep 1991
SYSTEMATE CREATININE (EPOS APPLICATION) #65413
K905658 · Em Diagnostic Systems, Inc. · May 1991
ROCHE COBAS READY CREATININE REAGENT
K902561 · Roche Diagnostic Systems, Inc. · Sep 1990
SYSTEMATE CREATININE TEST (CREA) #65413
K895022 · Em Diagnostic Systems, Inc. · Oct 1989
CREATININE TEST (CREA) ITEM #65663
K884734 · Em Diagnostic Systems, Inc. · Dec 1988
PARAMAX CREATININE REAGENT
K873531 · Baxter Healthcare Corp · Nov 1987